OWP PHARMACEUTICALS, INC. filed a Form D with the Securities and Exchange Commission on 2025-09-09.
OWP PHARMACEUTICALS, INC. filed a Form D notice of an exempt securities offering with the SEC on September 9, 2025. The filing reports $2.40M sold. Its industry group is Pharmaceuticals. It names SCOTT BOYER (Executive Officer, Director), BRUCE DUNCAN (Director), TROY HAMMOND (Director) (SEC Form D, September 9, 2025).
Is this your company?
Sell to companies like OWP PHARMACEUTICALS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns OWP PHARMACEUTICALS, INC.
Free to see. No signup.
More on the people and the money behind OWP PHARMACEUTICALS, INC., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when OWP PHARMACEUTICALS, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when OWP PHARMACEUTICALS, INC. raises, hires or launches. No email unless you switch it on.
Watch OWP PHARMACEUTICALS, INC. →Get the full cited report on OWP PHARMACEUTICALS, INC.
What the filing shows about OWP PHARMACEUTICALS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on OWP PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives OWP PHARMACEUTICALS, INC.'s address as 701 Warrenville Road, Suite 200, Lisle, IL 60532.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on OWP PHARMACEUTICALS, INC. See pricing
OWP PHARMACEUTICALS, INC. is a registered filer with the SEC (CIK 2037010) and has filed since 2024-09-16. 2 filings are on record, the latest on 2025-09-09.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
OWP PHARMACEUTICALS, INC.'s Form D of 2025-09-09 names SCOTT BOYER, BRUCE DUNCAN, TROY HAMMOND and 3 more as its officers, directors or promoters.
Its new offerings report $5.14M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Scott Boyer is named as Executive Officer and Director on the Form D that OWP PHARMACEUTICALS, INC. filed with the SEC on 9 September 2025, one of 6 people that filing names.
Bruce Duncan is named as Director on the Form D that OWP PHARMACEUTICALS, INC. filed with the SEC on 9 September 2025, one of 6 people that filing names.
Troy Hammond is named as Director on the Form D that OWP PHARMACEUTICALS, INC. filed with the SEC on 9 September 2025, one of 6 people that filing names.
Steve Bourne is named as Executive Officer on the Form D that OWP PHARMACEUTICALS, INC. filed with the SEC on 9 September 2025, one of 6 people that filing names.
Kurt Florian is named as Director on the Form D that OWP PHARMACEUTICALS, INC. filed with the SEC on 9 September 2025, one of 6 people that filing names.
Matt Litfin is named as Director on the Form D that OWP PHARMACEUTICALS, INC. filed with the SEC on 9 September 2025, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2025-09-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about OWP PHARMACEUTICALS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on OWP PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on OWP PHARMACEUTICALS, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist OWP PHARMACEUTICALS, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind OWP PHARMACEUTICALS, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for OWP PHARMACEUTICALS, INC.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Chicago
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/owp-pharmaceuticals-inc-form-d-25000001